Threshold Pharmaceuticals (THLD) Releases Quarterly Earnings, Beats Estimates By $0.16 EPS
Threshold Pharmaceuticals (NASDAQ:THLD) issued its quarterly earnings data on Monday. The company reported $0.02 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.14) by $0.16, Analyst RN reports. The company had revenue of $3.20 million for the quarter, compared to the consensus estimate of $3.15 million.
Shares of Threshold Pharmaceuticals (NASDAQ:THLD) opened at 4.17 on Monday. Threshold Pharmaceuticals has a 52-week low of $3.95 and a 52-week high of $6.11. The stock’s 50-day moving average is $4.63 and its 200-day moving average is $5.01. The company has a market cap of $242.2 million and a price-to-earnings ratio of 43.44.
Threshold Pharmaceuticals, Inc is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors and the bone marrows of some hematologic malignancies (NASDAQ:THLD) as treatments for patients living with cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.